Work

Targeting the ROCK2-BACH1-CXCL5 axis alleviates sepsis-induced liver injury by restoring protective neutrophil recruitment

Year: 2026
Type: preprint
Abstract: Sepsis-induced liver injury (SILI) is a fatal complication characterized by dysregulated immune responses. While early hepatic recruitment of neutrophils is critical for host defense and bacterial clearance, the molecular brakes that aberrantly restrict this protective mechanism during SILI remain poorly understood. Here, we identify Rho-associated coiled-coil-containing protein kinase 2 (ROCK2) as a pivotal upstream driver of SILI. ROCK2 is markedly upregulated in septic livers, and its genetic deficiency significantly improves survival, attenuates hepatic damage, and suppresses inflammation in septic mice. Furthermore, ROCK2 exacerbates SILI by impairing CXCL5-mediated hepatic neutrophil recruitment. Mechanistically, we uncovered a non-canonical mechanism wherein ROCK2 physically interacts with the transcription factor BACH1, competing with ubiquitin to prevent its proteasomal degradation. This aberrant stabilization enables BACH1 to directly occupy the CXCL5 promoter, silencing its transcription and dampening protective neutrophil infiltration. Overexpression of BACH1 or knockdown of CXCL5 abolished the hepatoprotective effects of ROCK2 deficiency. Moreover, we identified the natural compound epigallocatechin-3-gallate (EGCG) as a potent ROCK2 inhibitor. Pharmacological targeting of ROCK2 with EGCG effectively relieved BACH1-mediated repression, restored CXCL5 expression and neutrophil recruitment, and ameliorated SILI. Collectively, our findings delineate a novel ROCK2-BACH1-CXCL5-neutrophil pathogenic cascade, highlighting a unique kinase-mediated competitive stabilization of a transcription factor, and establish ROCK2 as an actionable therapeutic target for sepsis.
Language: English
Field: Medicine
Open Access status: green
OpenAlex ID: W7235871014
Cites: 57
Cited by:
Related to: 10